← Back to Clinical Trials
Recruiting NCT04142697

NCT04142697 Human Visual and Vestibular Motion Perception Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04142697
Status Recruiting
Phase
Sponsor University of Rochester
Condition Vestibular Disease
Study Type INTERVENTIONAL
Enrollment 300 participants
Start Date 2020-09-15
Primary Completion 2026-09-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
Heading direction adaptation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 300 participants in total. It began in 2020-09-15 with a primary completion date of 2026-09-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose this study is to measure sensitivity to visual and vestibular or balance motion. It is hoped that the results may help researchers better understand how aging and disease affect motion perception.

Eligibility Criteria

Inclusion Criteria: Healthy subjects: * general good health Vestibular Disease patients: * general good health * specific unilateral or bilateral vestibular loss Exclusion Criteria: Healthy subjects: * subjects who are institutionalized or otherwise not self-sufficient. * enduring sequelae due to diseases of the nervous system, eyes, ears, head and neck, and limbs, except for changes commensurate with normal aging (e.g. presbyacusic hearing loss, mild cataract, etc.). * abnormal cognitive function, which if in question can be determined as a score of \<27 on the Mini-Mental State test. * corrected visual acuity worse than 20/20 up to age 65, worse than 20/40 if \>65 * abnormal binocular stereo-acuity or visual fields. * any defects in cranial nerve, oculomotor, cerebellar/coordination, and somatosensory functions. * any abnormal oculomotor and vestibular function (caloric tests) Vestibular Disease patients: * Inability to perform the study tasks due to sensory, motor, or postural limitations

Contact & Investigator

Central Contact

Cesar Arduino

✉ Cesar_Arduino@urmc.rochester.edu

📞 585-273-2043

Frequently Asked Questions

Who can join the NCT04142697 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Vestibular Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04142697 currently recruiting?

Yes, NCT04142697 is actively recruiting participants. Contact the research team at Cesar_Arduino@urmc.rochester.edu for enrollment information.

Where is the NCT04142697 trial being conducted?

This trial is being conducted at Rochester, United States.

Who is sponsoring the NCT04142697 clinical trial?

NCT04142697 is sponsored by University of Rochester. The trial plans to enroll 300 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology